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Identification of promoter activity and differential expression of tran-
scripts encoding the murine stromelysin-I gene in renal cells. Stromely-
sin-i, matrix metalloproteinase-3 (MMP-3), is an important endopepti-
dase selectively expressed by somatic cells in organ tissues. The renal
tubulointerstitium, for example, comprises tubular epithelium and inter-
stitial fibroblasts forming the principal mass of the kidney. We observed
that mRNA encoding stromelysin-1 is detectable in murine renal fibro-
blasts, but not in proximal tubular epithelium. Transcripts measured by
RNase protection assay in renal fibroblasts increase following exposure to
phorbol ester, and thereafter, activated stromelysin-i protein can be
detected in culture media by Western blotting. A 6.4 Kb genomic clone
containing the putative stromelysin-1 promoter was isolated and a relevant
2.1 Kb PstI restriction fragment including 2.1 Kb of the immediate
5'-flanking region was sequenced on both strands. Two transcriptional
start sites were identified by primer extension; the major start site
corresponded to a previously established position in the rat promoter, and
a second undescribed minor transcriptional start site was located 16 bp
upstream of the primary site. A HiNF-A chromatin-activating element at
—106 bp was found in the early promoter region of pR336 and an active
AP-1 site at —72 bp with an EtsIPEA-3 motif at —203 bp was suggested by
transient transfection of luciferase minigenes into renal fibroblasts respon-
sive to phorbol ester. This Ets element was identical to a site in the early
promoter of the fibroblast-specific gene FSP1. A baseline enhancement in
activity of pR336 in fibroblasts was further observed with the addition of
5' flanking sequence Out to —1980 bp. This additional region of flanking
sequence contains two modular regions: one of multiple PEA-3 elements
between —684 bp and —1955 bp and a second region between —1929 bp
and —1980 bps containing a second AP-1 site at —1929 bp, a MBF-1/
MEP-1 metal binding site, and a PPAR peroxisome proliferator element
at —1950 bp. Our findings implicate a gene structure with expected activity
in a mesenchymal phenotype. The PKC-dependent regulation of the
stromelysin-1 gene supports the notion that it may be modulated during
inflammation or tissue remodeling.
Matrix metalloproteinases (MMPs) play a demonstrable role in
the maintenance of extracellular matrix. These latent proenzymes
are derived from the ancestral matrilysin gene and secreted by
many cell types [1—41. They may he activated by other proteinases
and are stoichiometrically inhibited by their physiologic inhibitors,
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tissue inhibitors of metalloproteinase [1, 5, 61. Non-pathogenic
roles of MMPs include morphogenesis, tissue remodeling, wound
repair, cell growth, and gland involution [7—10]. Alterations in
matrix turnover are biologically important and contribute to
several forms of pathologic damage. Among these are renal
inflammation, tumor metastasis, cartilaginous destruction in rheu-
matoid arthritis, sinusoidal degradation in pre-cirrhotic liver, and
possibly atherogenesis [11—181.
The MMPs can be categorized into the following three groups
based on substrate specificity: collagenases, gelatinases, and
stromelysins [1, 6, 17]. So-named for their broad range of speci-
ficity, the stromelysins distinguish themselves from the collage-
nases by their activity against several structural matrix glycopro-
teins, including fibronectin and laminin, gelatins and collagens
types III, IV, V, and IX. In addition, stromelysin-1 or MMP-3 can
superactivate the 92-kDa type IV collagenase to participate in a
proteolytic cascade with other MMPs [1, 6, 17, 19].
The expression of the stromelysin-1 gene is modulated by a
variety of tumor promoters and cytokines, including phorbol
esters, TGFI31, IL-i, and TNFa [20—25]. These biologic mediators
are synthesized by participant cells during inflammation and
consequently possess a capacity to modulate matrix degradation
through their respective influences on MMPs. Targets for these
proinflammatory mediators include mesenchymally-derived cells,
particularly fibroblasts [26—28]. Fibroblasts from several species
have been shown to respond to such mediators by synthesizing
and secreting MMPs. Because fibroblasts elaborate both collagens
and metalloproteinases, they are well positioned to modify sur-
rounding matrix. Not all fibroblasts, however, are the same [28].
The microenvironment from which they derive can influence their
phenotype [28, 29], and this environmental imprint may reflect
their ancestral pedigree as epithelium [30].
Tissue fibrosis is the extended correlate of fibroblast activity
[28, 29, 31, 321, and the binding of local growth factors within
matrix may also serve to modulate their cellular functions [9, 33,
341. We used tubulointerstitial fibroblasts to begin studying the
expression of the murine stromelysin-i gene.
METHODS
Cell culture
NIH 3T3 fibroblasts, TFB fibroblasts and MCT tubular epithe-
hum were cultured in DMEM (JRH Biosciences, Lenexa, KS,
USA) containing glucose 450 mg/dl, 10% fetal calf serum, 2 ms'i
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L-glutamine, penicillin 100 U/mi and streptomycin 100 jig/mI in
5% C02, 95% air at 37°C [28, 35]. Cells were passaged into 75 cm2
flasks or 6-well plates (Costar, Cambridge, MA, USA) after mild
trypsinization, grown to near-confluence and serum-deprived for
24 hours before addition of either TGF/31 0.1 to 1.0 ng/ml (R&D
Research, Minneapolis, MN, USA), or PMA, tetradecanoyl-12-
O-phorbol-myristate-13-acetate (Sigma Chemical Co., St. Louis,
MO, USA) at concentrations ranging from io to 10_6 M.
Control cells received equal volumes of ethanol vehicle.
eDNA library screening
Five micrograms of total cellular RNA were extracted from
MCT cells that had been exposed to either ethanol vehicle, PMA
(10—u to i0 M), or TGF/31 (0.1 to 1.0 ng/jil) for 8 to 24 hours.
After reverse transcription, second strand synthesis was accom-
plished by PCR in co-amplification reactions with 32P-dCTP.
Primer pairs were selected from a conserved portion of the human
stromelysin-1 cDNA sequence (5'-primer, CTGGAGGTTTGAT-
GAGAAGA; 3 '-primer, AAACCAGCTGTTGCTCTTCAA).
Amplification reactions were carried out for 35 cycles and radio-
active PCR products electrophoresed on 1.8% agarose gels. A 205
bp stromelysin-1 amplicori (5E22S) was excised from low-melt
agarose, random primed with 32P, and used to probe a TFB
fibroblast library in UniZap vector (Stratagene, La Jolla, CA,
USA) [30]. Plaques were lifted onto duplicate nitrocellulose
filters, denatured and immobilized by ultraviolet cross-linking.
Prehybridization for six hours at 42°C in a solution of 3 X SSC,
0.2% SDS, 200 jig/ml heparin, 50 mvt NaH2PO4 and 10 jig/mi
polyadenylic acid, and hybridization for 12 to 16 hours at 42°C in
a solution containing 106 cpm of probe/mi was followed by three
washes (2 >< SSC, 0.1% SDS for 20 mm at 56°C). Filters were
autoradiographed with intensifying screens for 16 hours. Phage-
mid rescue into pBluescript SK- and DNA sequencing of tertiary
plaques yielded four clones.
Northern analysis
Cultured cells were washed in PBS and total cellular RNA
isolated after lysis in either 4 M GSCN buffer [35] or RNAzoI B
(Cinna/Biotecx, Houston, TX, USA). Enrichment for po1y-(A)
fractions from total RNA was performed by oligo-d(T)-cellulose
column chromatography [30]. Fractionation of RNA was per-
formed on denaturing gels, capillary transferred to nylon mem-
branes, and fixed by UV-light cross-linking. Membranes were
hybridized with two mouse stromelysin-1 cDNA probes, p4A2 and
pTRI I a (gift of L. M. Matrisian, Nashville, TN, USA). Blots were
stripped and rehybridized with mouse cDNA encoding GAPDH
to assess sample loading.
RNase protection assay
A 134 bp PstI fragment from the 5'-terminus of our stromely-
sin-i cDNA p4A2 was subcioned into the PstI restriction site of
pGEM3Zf(+), to generate suhclone p4AG1. After XbaI linear-
ization of p4AGI, reverse transcription was initiated from the SP6
promoter using a Gemini Riboprobe II kit (Promega, Madison,
WI, USA). After DNase I treatment and phenol-chloroform
extraction, 0.5 to 1.0 x 106 cpm of riboprohe was hybridized to 70
to 100 jig of RNA at 55°C for 40 minutes [30, 35], Hybridized
samples were treated for 30 minutes at 25°C with RNase AJT1
(160 jig/mI; 12,000 U/mI) and Proteinase K (10 jig/mI) at 37°C.
Protected fragments were electrophoresed on 6% denaturing
polyacrylamide gels and autoradiographed at —70°C with inten-
sifying screens after 24 hours.
Primer extension
A reverse primer was synthesized from the region +35 to +55
bp defined by our cloned stromelysin-l cDNA p4A2 (5'-CACAG-
CAGGACCGGAAGACCC-3'). The primer was 5'-endlabeied
by polynucleotide kinase with 32P-dCTP (3000 Ci/mmol; DuPont
NEN, Boston, MA, USA), purified by elution from an Elutip-d
column (Schleicher & Schuell, Keene, NH, USA). Primer exten-
sion was carried Out as described previously [361. Either 50 jig of
total or 10 jig of poly-(A) RNA from phorboi ester treated TFB
cells was annealed with labeled primer (5 x i0 cpm) for five
minutes at 65°C in annealing buffer containing 20 mivi Tris-HCI
(pH 8.3) and 50 mvi KC1. Negative control reactions were
performed with 10 jig of wheat germ RNA. In a final reaction
volume of 40 jil containing 50 mivi Tris-HCI (pH 8.3), 10 mM
MgCl2, 5.0 mivi DTT, 125 mvi KCI and 4.0 mrvi dNTPs and 10 units
of rRNAsin (Promega), extension run-off products were synthe-
sized at 42°C for 45 minutes in the presence of 50 units of AMV
reverse transcriptase (Promega). The reaction was terminated by
the addition of 1 pA of 0.5 M EDTA. Extension products were
electrophoresed on 8% denaturing polyaciylamide gels alongside
sequencing reaction products obtained after annealing the
genomic stromelysin-1 clone pCP2.la with the antisense primer
used for primer extension. Extension run-off products and se-
quencing reactions were visualized by autoradiography.
Genomic library screening
LE392 cells were infected with a genomic NIH 3T3 fibroblast
library in Lambda Fix II (Stratagene). Plaques were screened for
three rounds with subclone p4AG1. This clone comprised 134 bp
of the 5'-terminus of cDNA, p4A2. Following prehybridization as
previously described, nitrocellulose filters were hybridized at high
stringency for 14 hours in a hybridization solution with 0.5 to
1.0 x 106 cpm of probe per ml [37]. Filters were washed three
times at increasing stringency and then autoradiographed. One
positive clone from tertiary screening was isolated and subcloned
into a NotI restriction site of pBluescript II.
Southern analysis and subcloning of the mouse stromelysin-1
promoter
Multiple restriction enzyme digests, including Pstl and Rsal cuts
of plasmid pN6l and genomic mouse DNA from mouse tail DNA
were electrophoresed on 1% agarose gels [38]. DNA fragments
were transferred to nylon membranes using the Turboblot system
(Scleicher & Schuell) and probed with clone pCP2.la (putative
—2.1 kbp stromelysin-1 promoter region) after prehybridization
and hybridization in Qwik-Hyh according to manufacturer speci-
fications at 50°C (Stratagene). Membranes were washed 3 times
(2 X SSC + 0.1% SDS at 56°C) and then autoradiographed. A
single PstI restriction fragment of pN6l was hybridized by
pCP2.la, isolated, purified and subcloned into pBluescript 11 K/S
(Stratagene). Multiple RsaI fragments of less than 0.4 khp were
hybridized by pCP2.la. In a separate experiment, the largest RsaI
fragment, representing the 370 bps of the 3' terminus of pCP2.la,
was subcloned into vector pBluescript II (Stratagene) to generate
plasmids pRSA-l.
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DNA sequencing
Bi-directional dideoxy chain termination sequencing of strome-
lysin-1 cDNAs and genomic clones was performed in the presence
of 35S with T3, T7 and sequence-specific primers and Sequenase v.
2.0 [30, 38]. Extension products were electrophoresed on 6%
acrylamide and autoradiographed for 16 hours. Homology matrix
analysis, sequence alignment and verification of restriction sites
were performed using a commercial software package MacVector
v. 5.0 (Kodak IBI, Rochester, NY, USA).
Construction of luciferase reporter plasmids
Sequence analysis of the 0.37 kbp stromelysin-1 subclone,
pRSA-1, demonstrated a high degree of homology to other
mammalian stromelysin-1 promoters [30, 39]. To examine the
relative promoter strength of the 5'-flanking region of the strome-
lysin-1 gene, two luciferase reporter constructs were constructed.
Two stromelysin-1 promoter fragments sharing a common 3'-
terminus were synthesized by PCR. Primer pairs were derived
from the 5' and 3'-ends of the pRSA-1 sequence and the
5'-terminus of the pCP2.la sequence with the 3' terminus for both
constructs ending at +36. One primer pair spanned 372 bp of the
stromelysin-1 promoter pCP2.la and included 336 bp proximal to
the putative transcriptional initiation site of stromelysin-1, iden-
tified by sequence analysis of pRSA-1 (5'-primer TTGTA-
CAACYI'GGACTTVFFAC; 3' -primer TCTGTACCACCT-
TCAGTAGG). A second primer pair spanned 2016 bp of
pCP2.1 a (5 '-primer CTGCAGAAGTACCTAAGGGAAC). PCR
products were amplified for 35 cycles and ligated into the TA
cloning vector for sequencing (Invitrogen, Sorrento, CA, USA).
Antisense orientation inserts were excised by XhoI and HindilI
restriction enzymes for sense orientation into the HindIII/XhoI
restriction sites of luciferase reporter vector, pGL-2 (Promega).
One construct designated pR1980 contained 2016 bp of pCP2.la
and 1980 bp proximal to the putative transcriptional start site of
the stromelysin-1 promoter. The second 372 bp construct desig-
nated pR336 contained 336 bp proximal to the putative transcrip-
tional start site. All sizes and orientations of inserts were verified
by restriction mapping and DNA sequencing. Large-scale DNA
preparations of purified plasmid were prepared for use in trans-
fection studies (Qiagen, San Diego, CA, USA).
Plasmid transfection
TFB cells were plated into six-well plastic dishes at a density of
3.3 X i0 cell/cm2 and grown for 24 hours in 10% FCS/DMEM in
3 ml cultures [30, 39I Cultures were transfected in fresh medium
with either 10 p.g of pR366 or pR1980 DNA, utilizing a modified
calcium-phosphate transfection method (Stratagene). All cultures
were co-transfected with 1 p.g of the pSV beta-galactosidase
reporter vector (Promega). DNA/calcium-phosphate precipitates
were removed from cultures after 16 to 18 hours by aspiration of
medium followed by three washes with calcium and magnesium-
free PBS buffer. Fresh medium was added, and after 6 to 8 hours
either phorbol ester or ethanol vehicle treatment was applied
followed by 24 hours of incubation.
Transfection assays
At the completion of culture incubations, cell media were
aspirated and the cells washed 3 times in 2 ml of PBS then lysed
in 100 p.l of cell lysis reporter buffer (Promega). The cell lysates
were centrifuged for two minutes at 16,000 rpm and frozen at
—70°C. Luciferase activity was assayed by a modification of the
method of de Wet [30, 39]. Light emissions were measured
directly and integrated over 20 second intervals at 25°C following
addition of 20 p.1 of freeze-thawed lysate to 100 p.1 of D-luciferin
in a Lumat LB 9501 luminometer. Blanking reactions contained
equal volumes of lysis reporter buffer and background values were
subtracted from experimental values. Relative luciferase activity
was obtained by dividing light output in a sample by its respective
beta-galactosidase activity, measured by chlorophenol red-j3-D-
galactopyranoside (Calbiochem, San Diego, CA, USA) deter-
mined by light absorbance at wavelength 600 nm. Cultures
transfected with the parent vector provided negative controls and
were consistently equivalent to blank values, indicating the ab-
sence of cryptic promotion of luciferase in the parent vector. Data
were expressed as the ratio of a construct's luciferase activity
divided by the luciferase activity of unstimulated pR336 vector
(representing unity) in each experiment (N 4). Data are
reported as mean SEM. for each group. Significant differences
among groups were determined by one-way analysis of variance
and between-group comparisons were made by using the Student-
Neuman-Keuls test.
Immunoblotting
Supernatants from TFB cells grown in serum-free medium for
24 hours were concentrated 10-fold, resuspended in SDS-sample
buffer at 25°C and subjected to SDS-polyacrylamide gel electro-
phoresis in a discontinuous buffer system [40]. Proteins were
immobilized on methanol-activated PVDF membranes (Dupont
NEN) by electrophoretic transfer in buffer containing 25 mM
Tris-HC1, 192 mrvi glycine (pH 8.3) and 0.1% SDS at 4°C.
Nonspecific protein binding was eliminated by incubating mem-
branes overnight in 5% casein/Tween-TBS (Tris-buffered saline).
After washing membranes two times (10 mm per wash) in 2%
BSA in Tween-TBS, blots were incubated in Tween-TBS for two
hours at 25°C with a polyclonal anti-human stromelysin-1 anti-
body (Binding Site; La Jolla, CA, USA). Membranes were washed
in Tween-TBS (4 X 10 mm) and incubated with secondary
antibody and then washed again (4 X 10 mm) in Tween-TBS.
Streptavidin horseradish peroxidase (1:1000 dilution) was added
to the mixture for one hour and the membrane washed again in
Tween-TBS (4 X 10 mm). Antibody detection was performed by
autoradiography using an Amersham ECL Kit (Arlington, IL,
USA).
Zymography
The conditioned media from serum-free quiesced HT 1080
fibrosarcoma cells (ATCC, Rockville, MD, USA) and TFB cells
stimulated with either PMA (10 M) or ethanol vehicle for 24
hours were concentrated 10-fold in Centricon concentrators
(Amicon). Ten microliter aliquots from each condition were
electrophoresed on 1% casein impregnated denaturing SDS 7.5%
polyacrylamide gels, in a discontinuous buffer system. Following
electrophoresis, gels were washed free of SDS by 3 rinses in 2.5%
Triton X-100 (vol/vol). Proteins were renatured at 37°C for 6 to 14
hours in a solution containing 50 mvi Tris-HCI (pH 7.6), 0.02%
Brij-35 (wt/vol), 5 mt CaCI2, and 0.2 M NaCI. Staining was
performed for three hours in 0.5% (wt/vol) Coomassie blue (30%
methanol, 10% acetic acid) and destaining in the same solution
without dye. Gelatinolytic activity was detected as a clear zones of
lysis against the blue background of undegraded casein.
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RESULTS
Tubular epithelium and fibroblasts constitute the bulk of the
renal cortex. Tin preliminary experiments, amplification reactions
with RNA from TFB fibroblasts using PCR primers deduced from
sequences of the human stromelysin-1 gene were used to deter-
mine if appropriate murine transcripts templated as amplicons. A
cDNA tubulointerstitial fibroblast library was then screened for
stromelysin-1 using PCR probe 5E22S. Four full-length clones
were isolated and sequenced. The longest clone, p4A2, was
sequenced in both orientations in its entirety. The appearance of
2 ATG codons within 6 bp of each other matched that of a
full-length murine cDNA isolated from mouse calvarial cells
subsequently reported by Hammani et al [411. The sequence of
p4A2 contains five more base pairs upstream of their cDNA, but
is otherwise identical. Although the initial ATG is usually used as
the translational start site, the second ATG in p4A2 (+58 bp; Fig.
1) likely represents the transcriptional start site by virtue of the
more favored context of this initiation codon triplet [42, 43]. The
sequence AATAAA represents the eukaryotic polyadenylation
signal found in 53% of mammalian sequences and is located at
+ 1743 bp (data not shown). The longest open reading frame of
the p4A2 is 1431 bp and spans the region +58 to 1489 bp.
Translation of the open reading frame encodes a protein of 477
amino acids with a structure expected for a metalloproteinase
([411; current data not shown). A leader sequence of 17 residues
is followed by a "pre" domain, cysteine switch and domain
structures characteristic of the stromelysins [1, 5, 6]. The calcu-
lated molecular mass of the protein was —53 kDa, consistent with
predictions ranging from 53 to 58 kDa in other species [1, 19].
5' Mapping of mRNA encoding of the mouse stromelysin-1 was
achieved through primer extension analysis (Fig. 2). A 21 base
reverse-primer, incorporating the p4A2 eDNA sequence from
+63 to +83 bp, was used to initiate reverse transcription. Major
and minor transcriptional start sites were identified in Figures 1
and 2; the major start (+ 1 bp; AGG) and minor (—16 bp; AAG)
transcriptional initiation sites were defined 58 and 74 bp proximal
to the first translated AUG. The major start site corresponds to
that previously determined in the rat stromelysin-1 promoter;
however, a secondary transcriptional initiation site had not been
detected within the rat genome [44].
Tertiary screening of plaques that hybridized to p4AG1, the
5'-terminus probe of p4A2 eDNA, isolated a 6.4 kbp genomic
clone, pN6l. A —2100 bp PstI restriction fragment and a -—370 bp
RsaI fragment were isolated from pN6l and subcloned into vector
pBluescript II for DNA sequencing, generating pCP2.la and
pRSA-1, respectively. Both fragments were also identified on
Southern blot with wild-type gcnomic DNA (Fig. 3). Bidirectional
sequencing of pCP2.la was performed and the upstream sequence
of the mouse stromelysin-l promoter (mST1) is aligned in Figure
I for comparison to rat (rST1). The sequence of pRSA-1 was
entirely contained within the larger stromelysin-1 promoter sub-
clone. Similar to the rat stromelysin-1 promoter, the sequence
contains a CAAT box at —78 to —74 bp and a TATAA box at —33
to —29 bp. A number of cis-acting motifs are found in the
5'-flanking region of murine stromelysin-i (Table 1). Analogous
to stromelysin-1 in other species [45, 46], a proximal AP-1 binding
site is present (at —72 to —66 bp in mouse) and contains the
consensus sequence TGAGTCA. A modified Ets-1/PEA-3 site
was also identified at —810 to —805. This site is nearly identical
with a candidate fibroblast-specific response element in the FSPI
gene [47]. An NF-IL-6-like element (TTCCGCNN) is located
upstream of the AP-1 site at —1252 to —1245 bp. The location for
this cis-acting element is similar to that described in the human
stromelysin-1 promoter of HepG2 cells [451. Two 5-bp PEA-3
consensus sequences (MGGAW) sites, which have Ets-like bind-
ing capacity [46], are located upstream at —209 to —205 bp and in
reverse orientation at —200 to —196 bp [1, 44, 45]. Overall,
sequence comparisons of the stromelysin-1 rat and mouse pro-
moter confirm approximately 90% homology between them for
the region spanning —Ito —310 bp, with increasing divergence
further upstream [44].
The induction of the stromelysin-1 transcripts by PMA was
examined in TFBs. Initial PCR reactions were used to determine
the optimal concentration of phorbol ester to produce enhanced
quantities of amplicons (10—v M was the most effective concentra-
tion; data not shown). Northern blot analysis of 30 sg of total
cellular RNA was performed using p4A2 as the probe. A single
distinct 1.9 kb transcript was detectable in control NIH 3T3
fibroblasts (Fig. 4; Lane 1), but not in proximal tubular cells (Fig.
4; Lane 3). After 24 hours of serum deprivation followed by eight
hours of incubation with iO— M PMA, renal fibroblasts, but not
proximal tubular cells, increased their transcripts encoding
stromelysin-1. The size of the stromelysin-1 transcript 1.9 kb is
consistent with homologues from rabbit, human, and rat species
[15, 41]. The specificity of hybridization of p4A2 for murine
stromelysin-1 was confirmed after stripping blots and rehybridiz-
ing them with pTRlla, a partial-length mouse stromelysin-l
eDNA.
Antisense RNA was generated by reverse transcription from
the SP6 promoter of p4AGI (specific activity, 0.5 X 1O cpm/sg
RNA) and hybridized to 50 to 100 sg total cellular TFB RNA in
order to study the effects of PMA on levels of stromelysin-l
transcripts. The run-off RNA protected 134 bases of the 5'-
terminus of the stromelysin-1 transcript (Fig. 5). Serum-deprived
TFBs were exposed to PMA at i0 si for 8 to 24 hours. PMA
markedly raised stromelysin-1 transcript levels at 8 and 16 hours
with levels declining thereafter. In separate experiments, the
addition of serum to achieve a final concentration of 10% did not
change the intensity of the signal for stromelysin-1 in the absence
or presence of PMA (data not shown). By contrast, proximal
tubular cells demonstrated minimal or no signal for stromelysin-1,
irrespective of their exposure to PMA and/or serum (data not
shown).
Two luciferase reporter minigenes bearing the same 3'-termi-
nus (+36 bps) were constructed from the DNA sequences ob-
tained from pCP2.2 and pRSA-1. A 372 bp construct, p336,
contained the sequence of pRSA-1 and included 336 bp upstream
of the putative mouse transcriptional start site also identified in
rat transin-l. A 2016 bp construct, pR1980, included the 336 bp of
early promoter sequence in pR336 and an additional 1664 bp of
the 5'-fianking sequence.
In transient transfection assays with renal fibroblasts, the
relative luciferase activity of these two constructs and their parent
vector, pGL-2, were compared during exposure to 10 7M phorbol
ester PMA for 24 hours. Relative luciferase activity of pGL-2 was
near background and PMA had no effect on its transcriptional
activity (Fig. 6). Luciferase activity of pR336 was assigned a value
of 1.0 and phorbol ester treatment augmented luciferase activity
by 2.5-fold (P < 0.01); this increase is consistent with the presence
of an AP-1 site. Exposure to phorbol ester also increased relative
luciferase activity in the pR1980 construct from 3.8-fold to
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Met Lys
Fig. 1. Sequence comparison of the mouse stromelysin.1 promoter (mST1) with rat (rST1). A PstI fragment of the stromelysin-1 clone pN6l was
isolated and subcloned into pBluescript II, generating pCP2.la; 2141 bp of pCP2.ia are shown in alignment and comparison with the rat promoter
sequence from + ito —1250. Italics, CAAT box located at —78 to —74 bp. Single underscore, AP-1 site located at —72 to —66 bp. Italics, TATAA box
located at —33 to —29 bp. , minor transcriptional initiation site at nucleotide "A" at —16 bp. +1, major transcriptional start site at nucleotide "A" at
+ 1 bp. Translational start site (ATG) located at +57 to +59 bp with initial residues identified. Vertical dashes with capital letters refer to bp identities
and lower case letters in rST1 refer to bp differences with mST1.
5.9-fold (P < 0.01). The increase in promoter length between Using an anti-human stromelysin-1 antibody, we next probed
pR336 and pR1980 also augmented relative light output in both the conditioned media from renal fibroblasts treated with iO M
PMA-treated and control groups (P < 0.001). PMA for the presence of secreted stromelysin-i protein. A
Yee et a!: Stromelysin-1 in renal cells 125
Fig. 2. Primer extension analysis of the mouse stromelysin-1 gene. Fifty
picomoles of specific antisense primer for mouse stromelysin-1 was end-
labeled with 32Py-ATP by polynucleotidyl kinase and hybridized to 5 rg of
poly-(A) RNA, 50 rg of total cellular RNA from TFB cells or 50 j.g of
wheat germ RNA. Extension products were synthesized by reverse transcrip-
tase and electrophoresed alongside genomic DNA sequencing products
generated from the same antisense primer. pCP2.la. Lane 1. Wheat germ
RNA. Lanes 2 and 3. Extension products generated from 50 g of total
cellular RNA and 5 jg of poly-(A) RNA from TFB cells. Lanes GATC.
Nucleotide arrangement of extension products of the reverse complementaiy
DNA sequence of pCP2.la. Arrowheads denote two transcriptional initiation
sites. The major transcriptional initiation site is identified by the lower
arrowhead as an "A" and corresponds to + 1 bp, and the secondaiy initiation
site is identified by the upper arrowhead as an "A" at —16 bp.
characteristic stromelysin-1 doublet, migrating at Mr 54/48 kD on
SDS-PAGE was detected by Western blot (Fig. 7). Exposure of
the conditioned medium to plasmin, trypsin, or iodoacetic acid
resulted in the appearance of a stromelysin-1 catalytic domain of
the correct Mr (data not shown).
The proteolytic activity of renal fibroblasts was tested by casein
substrate zymography. Casein is degraded by stromelysin-1, but
not by the collagenases and gelatinases. Conditioned media from
HT 1080 fibrosarcoma cells and TFB cells exposed to either
ethanol vehicle or PMA (i0— M) for 24 hours were collected and
concentrated 10-fold. Equal volumes of supernatants were elec-
trophoresed on denaturing SDS-PAGE gels impregnated with 1%
casein that can detect nanogram amounts of metalloproteinase
activity (Fig. 8). After the proteins were renatured, a major
caseinolytic zone of lysis was demonstrated at Mr -54 kDa from
HT 1080 cells (Lane 2) and phorbol ester-treated TFB fibroblasts
(Lane 4), but not from non-stimulated renal fibroblasts (Lane 3).
The apparent molecular mobility of the mouse stromelysin-1
corresponded closely to those reported from other species. Pro-
teolytic activity was inhibitable by either EDTA-chelation or
exposure to l,10-o-phenanthroline and confirmed the identity of
the proteolytic species as a MMP (data not shown)
DISCUSSION
Renal tubulointerstitial fibroblasts (TFB) and proximal tubular
cells (MCT) from mice both respond to cytokines [28, 35],
1 2 3 4
Fig. 3. Southern blot analysis of mouse genomic DNA. A 6.4 kbp genomic
DNA fragment of the stromelysin-l promoter (pN6l) was isolated from a
lambdaphage library and subcloned into vector pBluescript II K/S(—).
Five microgram samples of pN6l and 10 jg samples of wild-type mouse
genomic DNA were digested with the restriction enzymes as indicated.
Restriction fragments were electrophoresed on a 1.8% agarose gel,
immobilized onto nylon membranes, and hybridized with 32P-labeled
DNA insert from pCP2.la, the —2100 kbp putative stromelysin-1 pro-
moter. The arrows mark the --2100 kbp PstI fragment and the —370 kbp
RsaI fragment containing the immediate up-stream 5'-fianking sequences
of the mouse stromelysin-1 promoter. Lanes 1 and 2 are from wild-type
mouse genomic DNA and lanes 3 and 4 are from pN6l.
elaborate extracellular matrix [28] and share a common ancestry
[30]. Their capacity to form or degrade local tissue infrastructure
depends on their state of differentiation and activation [5, 10, 24].
While proximal tubular cells differentially express transcripts for a
variety of adhesion molecules and matrix glycoproteins in re-
sponse to their microenvironment [48], fibroblasts tend to either
lose or increase their degradative capabilities through altered
expression of metalloproteinases and their inhibitory counterparts
[1, 49]. Both cell types, however, have the capacity to remodel
kidney parenchyma during pathological injury [17, 29, 50].
The assumption of a more degradative phenotype is associated
with matrix proteolysis. Within the kidney, several types of
proteinases are thought to be of pathogenic importance, including
cathepsins, plasminogen, and MMPs [17, 51—57]. Cathepsins are
aspartic and cysteine proteinases which degrade matrix either
intracellularly within phagolysosomes, or perhaps in a low pH
environment [17]. The serine protease plasmin, as well as neutro-
phil serine proteinases, can also degrade matrix components
solely, or in a cascading fashion in conjunction with other
proteinases. Plasmin is activated from plasminogen by plasmino-
gen activator or elastase, and once formed, can subsequently
superactivate MMPs 11, 6].
MMPs are neutral proteinases comprising the collagenases,
gelatinases, or stromelysins [17, 58]. MMPs in the kidney, partic-
ularly the gelatinases have been described in glomerular epithelial
cells [54] and mesangial cells [17, 59]. The differential expression
2 3 G A T C kbp PstI RsaI PstI Asalaa aa a
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Fig. 5. Ribonuclease protection assay of renal fibroblast RNA. TFB cellsTFB were cultured on plastic to 70% confluence, serum-deprived for 24 hours
— + and then treated with either ethanol as vehicle or PMA (10—v M) for 8, 16
and 24 hours. Fifty micrograms of yeast tRNA and total cellular RNA
from each condition were hybridized to antisense RNA generated by
reverse transcription from the SP6 promoter of stromelysin-1 cDNA
(p4AGl), in the presence of 32P-rUTP, rNTPs and RNA polymerase II.
Samples were digested with RNase AlT, and protected fragments were
electrophoresed on 7.5% denaturing polyacrylamide gels. Abbreviations
are: Left, sizing markers of MspI digestion of plasmid pBR322 in bases;
CON, positive control RNA from non-stimulated mouse mesangial cells;
Yeast tRNA, negative control; Probe, free probe. Arrow denotes pro-
tected fragments shown in experimental lanes at 134 bases.
been detected in this model [61]. Finally, tissue MMPs are also
expressed by neutrophils visiting a site of tissue destruction [18].
Stromelysins target nearly all components of the basement
membrane [31, 55], and the presence of glomerular basement
4 membrane fragments in urine from patients afflicted with glomer-
ulonephritis indirectly lends credence to a potential role in
inflammation [52]. Stromelysin-1, however, has been relatively
less well characterized to date [44], particularly in mouse, and this
is certainly true with regard to the tubulointerstitium of the
kidney.
The mass of normal tubulointerstitium principally comprises
the tubular segments of nephrons and lesser numbers of fibro-
blasts [301. Our findings in proximal tubular cells and fibroblasts
taken from this compartment and adapted to culture suggest that
expression of stromelysin-1 is limited to the fibroblast phenotype.
Low basal levels of stromelysin-1 are P MA-inducible, but only in
fibroblasts. The up-regulation of transcripts encoding the strome-
lysin-1 gene by phorbol ester is consistent with known properties
of mesenchymal cells obtained from diverse species, including
rabbit, human, and rat [1, 6].
Transfection of stromelysin-1 minigenes into renal fibroblasts,
under the influence of phorbol ester, produced significant incre-
ments in reporter activity. There is growing evidence that several
Table 1. Transcription factors in mouse stromelysin-1 promoter
Consensus
Motif sequence Position Reference
Early promoter region
of murine stromelysin-1
AP-l TGASTMA —72 to—66 [661
HiNF-A ATTTNNNNTTT —116 to —106 [671
Ets SMGGAWGY —210 to —203 [46, 68]
PEA-3 MGGAW —209 to —205 [46, 661
Distal promoter region
of murine stromelysin-1
NF-1L6 TKNNGNAAK —1252 to —1244 [69]
PEA-3 MGGAW —688 to —684 [46, 66]
PEA-3 MGGAW —896 to —892
PEA-3 MGGAW —1154 to —1150
PEA-3 MGGAW —1202 to —1198
PEA-3 MGGAW —1302 to —1298
PEA-3 MGGAW —1387 to —1383
PEA-3 MGGAW —1884 to —1880
PEA-3 NGGAW —1919to—1915
PEA-3 MGGAW —1955 to —1951
AP-1 TGASTMA —1929 to —1923 [661
MBF-1 TGCRCNC —1949 to —1943 [701
MEP-1 TGCRCNC —1949 to —1943 [71]
PPAR AGGTCA —1955 to —1950 [721
z8hr l6hr 24hr a
PMA — +— + — +0>- 0
242 —
180—
160— —134bp
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Fig. 4. Northern blot analysis of total cellular RNA. Total cellular RNA
was extracted from cell lines following 24 hours of serum-deprivation and
treatmcnt with either PMA 10- M or ethanol vehicle for eight hours.
Thirty microgram samples of total RNA were subjected to Northern blot
analysis, transferred to nylon membranes, hybridized with mouse strome-
lysin-1 eDNA (p4A2), and subjected to autoradiography with intensifying
screens for 24 hours. Lane 1. Total RNA from NIH 3T3 fibroblasts
(control). Lanes 2 and 3. Total RNA from MCT cells. Lanes 4 and 5. Total
RNA from TFB cells. Arrow denotes single 1.9 kb transcript for mouse
stromclysin-1.
of the 72 kDa type IV collagenase, PUMP-i and T1MP-i in
embryonic rat kidney suggests their importance in the morpho-
genesis of the developing nephron [60]. In murine polycystic
kidney disease, for example, abnormal matrix accumulates and the
changing expression of TIMP and MMP genes in early and
advanced stages supports a role for these proteins in the patho-
genesis of disease. Stromelysin-l and its proteolytic activity has
S
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Stromelysin-1 promoter constructs
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Fig. 6. Transient transfection assays of TFB cells with minigdnes report-
ing luciferase activity. 3 X iO TFB cells were co-transfected with either
10 jrg of parent vector (pGL-2), pR336 or pR1980 and 1 jg of the pSV
vector containing the beta-galactosidase gene (Promega). Precipitates
were washed off after 16 hours and followed by either a 24 hours exposure
to PMA iO M in experimental groups (•) or ethanol vehicle in control
groups (LI). Cells were lysed and assayed for luciferase activity by
luminometry. Data are expressed as mean SEM. and represent the ratio
of relative luciferase activity for a given condition divided by the luciferase
activity for untreated pR336, after correction of each for beta-galactosi-
dase activity (N = 4). Statistically significant differences among groups
were determined by one-way ANOVA. Two-group comparisons were
determined by the Student-Neuman-Keuls test. P < 0.001 for pR336
versus pR1980 and P < 0.001 for pR336/PMA versus pR1980/PMA.
members of the MMP gene family, like stromelysin-1 [46, 62],
collagenase [63], and tissue inhibitor of metalloproteinases-1 are
modulated by an interaction between AP-1 and Ets/PEA-like
cis-acting elements. An enhancer effect of phorbol ester in the
murine stromelysin-1 promoter is suggested by the increase in
luciferase activity between pR336 and pR1980 minigenes with the
addition of more sites. Although other proinflammatory cytokines
were not tested in our experiments, the proximity of cis-acting
elements inducible by PMA and IL-1f3 implies that genes like
stromelysin-1 are likely engaged during proinflammatory events
[13, 15]. The Ets-like sequence in the early promoter of mouse
stromelysin-1 is quite similar to a motif in the fibroblast-specific
FSP1 promoter [30], and raises the question of whether pheno-
type and synthetic capacity are linked by transcriptional controls.
Sequence analysis of the murine cDNA encoding stromelysin-1
demonstrates a high degree of conservation with rat [23, 46, 64,
65], and with the eDNA previously reported in mice [41]. The
mouse early promoter sequence is also highly conserved in
comparison to rat stromelysin-1, for the region spanning +1 to
—310 bp [45, 46, 64], and the positional relationship of several
promoter elements in this region from both species is nearly
identical. Analysis of the whole 1980 bp of upstream promoter,
however, did not disclose a TGF-inhibitory element (TIE) within
this region. Such TIE elements contain the consensus sequence
GNNTTGGtGa and have been localized within rat stromelysin-1,
Fig. 7. Identification of stromelysin-1 protein in conditioned medium.
3.3 X iO cell/cm2 TFB cells were quiesced in serum-free medium for 24
hours and then exposed to phorbol ester for 24 hours (PMA iO M).
Supernatants were collected and concentrated 10-fold. Twenty microliters
of concentrated conditioned medium was subjected to SDS-PAGE on
7.5% denaturing polyacrylamide gels and proteins transferred to and
immobilized on PVDF membranes. Stromelysin-1 protein was detected by
the ECL technique after exposure of the membrane to a polyclonal
anti-human stromelysin-1 antibody and appropriate secondaiy antibody.
Lane 1, Sizing markers. Lane 2, Concentrated conditioned medium from
TFB cells. Arrows denote the characteristic 54/48 kDa doublet for
stromelysin- 1.
human elastase and urokinase, and in mouse MRP genes (mito-
gen-related protein)/proliferin promoters [44]. In the rat strome-
lysin-1 gene the TIE element appears at —708 bp and interacts in
a complex manner with a fos/jun complex and mediates down-
regulation of stromelysin-1 gene expression in the presence of
TGF/31 [23].
In conclusion, our studies demonstrate that the mouse strome-
lysin-1 gene and protein is selectively regulated by phorbol ester.
We postulate that an induction of the stromelysin-1 gene in
fibroblasts by proinflammatory cytokines depends on a complex
interplay among local influences within the microenvironment,
including the availability of cells of the appropriate phenotype.
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Fig. 8. Caseinolytic activity of mouse fibroblast stromelysin-1. The con-
ditioned media from equal numbers (1 X iO cells) of HT 1080 fibrosar-
coma cells and TFB cells exposed to either ethanol vehicle or PMA
(10—v M) for 24 hours were harvested and concentrated 10-fold. Ten
microliter aliquots were electrophoresed on denaturing 7.5% SDS poly-
acrylamide gels containing 1% casein using a discontinuous buffer system.
Zones of proteolysis were detected after staining and destaining of gels.
Lane 1, Sizing markers. Lane 2, HT 1080 conditioned medium. Lanes 3
and 4, TFB conditioned media from ethanol and PMA-treated cells.
Arrow, Caseinolytic zones at Mr —54 kD appearing in HT 1080 and
PMA-treated TFB cells.
APPENDIX
The abbreviations used in this paper are: bp, base pair; kbp, kilobase
pairs; RTIPCR, reverse transcription/polymerase chain reaction; MMP,
matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase;
TGF, transforming growth factor; IL, interleukin; TNF, tumor necrosis
factor; IFN, interferon; TFB, tubulointerstitial fibroblast; MCT, murine
cortical tubule cells; DMEM, Dulbecco's Modified Eagle Medium; GSCN,
guanidinium isothiocyanate; RNase, ribonuclease; dNTP, deoxynucleotide
triphosphates; RT/PCR, reverse transcription/polymerase chain reaction;
AMV, avian myeloblastosis virus; rRNAsin, recombinant ribonuclease
inhibitor; RNase, ribonuclease; dCTP, deoxycytidine triphosphate;
GAPDH, 3-glyeraldehyde phosphate dehydrogenase; PMA, tetrade-
canoyl-1 2-O-phorbol-myristate-1 3-acetate; DNase, deoxyribonuclease;
DTT, dithiothreitol.
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